Glial cells in neuropathic pain
Physiological Reviews · 01.10.2026 · 106 (4) · 2079-2148
DOI: 10.1152/physrev.00034.2025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiological Reviews, erschienen am 01.10.2026. Verfasst von Temugin Berta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pain Research Center, Department of Anesthesiology, University of Cincinnati Medical Center, Cincinnati, Ohio, United States. Hauptthemen laut MEDLINE: Neuralgia, Neuroglia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 722 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Department of Defense (DOD), HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), NINDS NIH HHS.
Abstract (Originalsprache)
Neuropathic pain is a chronic, debilitating condition that affects ∼7–8% of the global population and remains difficult to treat because of limited therapeutic options. Over the past two decades, mounting preclinical evidence has highlighted the crucial role of glial cells in the development, maintenance, and resolution of neuropathic pain. Conditions such as peripheral nerve injury are associated with reactive responses of glial cells, namely microglia and astrocytes in the central nervous system and satellite glial cells in the peripheral ganglia. Under physiological conditions, glial cells contribute to homeostatic regulation of spinal nociceptive circuits, preserving normal pain sensitivity. However, neuropathic pain is increasingly recognized as a form of gliopathy, wherein dysregulated glial activity contributes to pain hypersensitivity through enhanced excitability of primary sensory neurons (peripheral sensitization) and neuronal plasticity in the central pain circuits (central sensitization). In this review, we provide a comprehensive overview of glial cell research in neuropathic pain, with a specific focus on microglia, astrocytes, and satellite glial cells, the most extensively studied glial types in this context. We also highlight the critical involvement of glial cells in neuroinflammation and neuro-glial interactions and evaluate emerging therapeutic strategies targeting glial mechanisms of neuropathic pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pain Research Center, Department of Anesthesiology, University of Cincinnati Medical Center, Cincinnati, Ohio, United States.
- Department of Anesthesia, Alan Edwards Centre for Research on Pain, Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec, Canada.
- Center for Translational Pain Medicine, Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, United States.
- Department of Neurobiology, Department of Cell Biology, and Department of Integrative Immunology, Duke Institute for Brain Sciences, Duke University Medical Center, Durham, North Carolina, United States.
ORCID-Profile: Temugin Berta, Arkady Khoutorsky, Jing Xu, Ru-Rong Ji
Förderung
- U.S. Department of Defense (DOD)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- NINDS NIH HHS
- Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Berta, T., Khoutorsky, A., Xu, J., & Ji, R. R. (2026). Glial cells in neuropathic pain. Physiological Reviews, 106(4), 2079-2148. https://doi.org/10.1152/physrev.00034.2025
Vancouver
Berta T, Khoutorsky A, Xu J, Ji RR. Glial cells in neuropathic pain. Physiological Reviews. 2026;106(4):2079-2148. doi:10.1152/physrev.00034.2025
BibTeX
@article{Berta2026,
author = {Berta, Temugin and Khoutorsky, Arkady and Xu, Jing and Ji, Ru-Rong},
title = {Glial cells in neuropathic pain},
journal = {Physiological Reviews},
year = {2026},
volume = {106},
number = {4},
pages = {2079--2148},
doi = {10.1152/physrev.00034.2025}
}
EUVIMED